Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial Profile


Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2008

At a glance

  • Drugs Atazanavir; Lamivudine/zidovudine; Lopinavir/ritonavir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms LORAN
  • Most Recent Events

    • 22 Feb 2008 New trial record.
    • 03 Feb 2008 24-week efficacy results have been presented (15th Conference on Retroviruses and Opportunistic Infections : abstr. 780).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top